Showing results (231-240 of 413) with videos related to
Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancerTanya B Dorff, Bryan Goldman, Jacek K Pinski, et al.World Journal of Urology|November 17, 2010
Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methodsIan M Thompson, Shady Salem, Sam S Chang, et al.Scientific Reports|March 1, 2016
Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation AnalysisYao Wang, Rohit Ramakant Jadhav, Joseph Liu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.Journal of the National Cancer Institute|September 14, 2012
Health-related quality-of-life findings for the prostate cancer prevention trialCarol M Moinpour, Amy K Darke, Gary W Donaldson, et al.Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.Journal of the National Cancer Institute|February 26, 2014
Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421Primo N Lara, Benjamin Ely, David I Quinn, et al.The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Obesity, adipokines, and prostate cancer in a prospective population-based studyJacques Baillargeon, Elizabeth A Platz, David P Rose, et al.Pageof 42